Antiglobulins or rheumatoid factors (RF) are found in the sera and synovial fluids of most patients with rheumatoid arthritis (Vaughan and Butler, 1962; Rodnan, Eisenbeis, and Creighton, 1963) . When the serum and synovial fluid from the same patient are compared, the titre of RF is usually higher in serum, but remarkably higher titres are occasionally present in synovial fluid, suggesting that both systemic and synovial immune systems contribute to the body's pool of RF (Bland and Clark, 1963; Hannestad and Mellbye, 1967) . However, the use of comparative titres to indicate the site of RF production does not take into account serum-synovial transport mechanisms. The normal synovium is permeable to a variety of low molecular weight proteins (Mackiewicz and Fenrych, 1961; Schur and Sandson, 1963) , and several dynamic studies have shown that radiolabelled albumin and IgG readily traverse the inflamed synovial membrane (Ahlstr6m, Gedda, and Hedberg, 1956; Rodnan and Maclachlan, 1960) . The only previous investigation on serum-synovial transport of a high molecular weight protein in rheumatoid arthritis was performed with a radio-labelled IgM cold agglutinin (Brown, Cooper, and Bluestone, 1968) . After intravenous administration, the IgM readily crossed the rheumatoid synovium, and reached and maintained a dynamic equilibrium between plasma and synovial fluid. Moreover, the IgM entered the joint space more slowly than labelled albumin, although the rate of exit into plasma was the same for both proteins. Those results primarily reflected the role of molecular size on synovial transport. An IgM possessing antiglobulin activity, however, may not behave in the same manner as an IgM which is inert at body temperature; its distribution and transport could be influenced by antigen-antibody complex formation, and whether or not such complexes continue to circulate or are sequestered by the reticulo-endothelial system or elsewhere (Benacerraf, Sebestyen, and Cooper, 1959) . The present investigation was undertaken to study the catabolism and serum-synovial transport of a purified antiglobulin in patients with inflammatory joint disease.
Methods Purification, Characterization, and Labelling of RF ISOLATION AND CHARACTERIZATION OF CRYO-GLOBULIN 30 ml. serum from a patient with mixed (IgG-IgM) cryoglobulinaemia was refrigerated at 4°C. for 48 hrs. After centrifugation at 4'C., the supernatant was removed and the cryoprecipitate redissolved at 37°C. in phosphate buffered saline, pH 7 0. Material which failed to redissolve was discarded and the clear supematant was kept at 4°C. for 48 hrs. The resulting cryoglobulin was centrifuged at 4°C. and washed in 20 ml. chilled phosphate buffered saline, pH 7 0; this cycle was repeated five times.
The components of the washed, redissolved cryoglobulin were identified in agar gel double diffusion using antisera monospecific for IgM, IgG, IgA, kappa and lambda light chains.* Antiglobulin activity was determined at 37°C., using latex particles coated with human aggregated gammaglobulin, human type 0 positive erythrocytes sensitized with anti-CD serum Ripley, and sheep red cells sensitized with rabbit gammaglobulin.
ISOLATION AND CHARACTERIZATION OF RHEUMA-TOID FACTOR
The cryoglobulin was redissolved at 37°C. in each of three buffers: 0 15 M sodium phosphate, pH 7 35; 0-2 M sodium acetate-acetic acid, pH 4-6; and 1 0 M glycine-HCI, pH 3 *0. Gel filtration was performed at room temperature over Sephadex G-200 columns; appropriate buffers were used as the eluents at flow rates of 10 ml. per hour. The integrity of each column had been previously shown by its ability to separate a mixture of dextran and albumin. Eluted peaks, measured spectrophotometrically 48 Annals of the Rheumatic Diseases at 280 mu, were dialysed against distilled water and concentrated by vacuum dialysis. Protein concentration was determined by the method of Lowry, Rosebrough, Farr, and Randall (1951) , and the immunoglobulins present in each peak were detected by agar gel double diffusion, using monospecific antisera. Immunoglobulin concentrations were determined by radial diffusion in agar-antibody platest and, in some instances, by the method of quantitative complement-fixation (Wasserman and Levine, 1961; Goldberg and Barnett, 1967) . Antiglobulin activities were measured at 37°C. and antinuclear antibody activity was detected by a double-layer technique using human leucocytes and fluorescein conjugated to antiserat monospecific for IgG, IgA, and IgM (Condemi, Barnett, Atwater, Jacox, Mongan, and Vaughan, 1965) .
LABELLING OF RHEUMATOID FACTOR
The isolated IgM was labelled with 125l by McFarlane's method (1963) , with the modifications of Helmkamp, Contreras, and Bale (1967) , to give a final activity of 50 ,uc./mg. IgM. Normal human albumin was added to prevent damage due to irradiation; 98 per cent. of the label was precipitated by the addition of trichloracetic acid (TCA). To confirm labelling of the IgM, 0 1 ml. radio-iodinated IgM solution was added to 0 * 9 ml. normal whole human serum; the mixture was subjected to Sephadex G-200 gel filtration, and the eluted peaks were tested for radioactivity content in a well-type gamma counter. § The labelled IgM preparation was also tested by radioimmunodiffusion, using antisera monospecific for IgG, IgA, IgM, kappa and lambda light chains, and by radioimmunoelectrophoresis against antiserum to whole human serum. Precipitin lines formed in 12 to 16 hrs and the agar slides were washed in phosphate buffered saline, pH 7 0, for 36 hrs with three changes of wash; the slides were dried on filter paper and placed agar-side down on No-screen x-ray film.I Films were developed at 6 hrs.
ANTIBODY ACTIVITY OF LABELLED RF
Rheumatoid factor and antinuclear assays were performed as already described. Cryoprecipitability of the labelled IgM was tested by adding excess normal human IgG and leaving the mixture at 4°C. for 12 hrs. The mixture was centrifuged at 4°C., the-supernatant.and cryoprecipitate separated, and each counted for radioactivity. Labelled IgM, without added IgG, was tested simultaneously as a control.
Patient Studies PATIENT MATERIAL
Five patients with gross knee joint effusions and one normal control subject were studied. Three patients had widespread sero-positive erosive rheumatoid arthritis, one had sero-negative psoriatic arthropathy, and one a chronic traumatic effusion. Rheumatoid factor titres and immunoglobulin levels were measured in the sera and synovial fluids of all five patients and in the serum from Radioactivity was counted in 1 ml. aliquots of each sample. Altemate specimens were mixed with 0 1 ml. of normal rabbit serum and 1 1 ml. of 20 per cent. TCA.
The resulting precipitates were centrifuged and washed and their radioactivity content was determined. For the plasma to synovial fluid transport study, the radioactivity in each sample was expressed as a percentage of the radioactivity present in the 15-min. plasma sample. For the synovial fluid to plasma transport study, the radioactivity in each sample was expressed as a percentage of the radioactivity present in the 30 min. injected-joint sample. Specific activities were plotted on semilogarithmic graph paper against time.
AUTORADIOGRAPHY
On the fourth day after the intra-articular injection of the labelled IgM, autoradiographic studies were performed on the synovial membrane obtained at synovectomy from the injected knee of one of the rheumatoid patients (Case 3). The tissue was immediately frozen in liquid nitrogen and sections, 2 to 4 M, were prepared on a cryostat at -20°C. The sections were fixed onto gelatin-coated slides with absolute methanol. AR-10 x-ray filml was then layered over the tissue and the films developed after 10 to 14 days at 4°C. The tissue was stained using a modified Giemsa technique (Feinendegen and Bond, 1962) .
Results

CRYOGLOBULIN CHARACTERIZATION
The re-dissolved washed cryoglobulin consisted of IgG and IgM immunoglobulins. At a concentration of 1 mg./ml., the cryoglobulin had a latex-agglutina- The initial peak eluted at pH 4 * 6, which had a protein concentration of 1 mg./ml., gave a latex-agglutination titre of 1:1,280 and a titre of 1 :128 when tested against Ripley sensitized red cells. The purified IgM (0f83 mg./ml.) obtained by gel filtration at pH 3-0 had a latex-agglutination titre of 1:10,240. After labelling, the IgM (0 * 6 mg./ml.) gave a latex titre 
Patient studies
The antiglobulin titres and immunoglobulin levels in the sera and synovial fluids of the five patients with joint disease are shown in the After intravenous injection, synovial fluid activities rose rapidly, reaching peaks of 17 to 35 per cent. of the 15-min. plasma level by 5 to 24 hrs. Levels then declined in parallel with the plasma activity; in all cases, the slope of the falls showed an initial steep component. In three patients, synovial sample activities were higher than the corresponding plasma samples once equilibrium between synovial fluid and plasma was established (Fig. 3) . The samples from two joints in the same patient showed almost identical activities (Fig. 4) . The radioactivity in the samples from the rapidly rising and steeply declining points on the synovial fluid curves were 21 to 70 per cent. TCA-precipitable; those from the later points (slowly declining in parallel with plasma activity) were 75 to 100 per cent. TCA-precipitable (Fig. 6) .
At all times during the study, free radio-iodine was detected in the subjects' urine in amounts compatible with the catabolism of the labelled IgM, the bulk being detected within the first 24 hrs. Activities in plasma and in synovial fluid from the contralateral joint rose quickly to peaks, and then declined gradually in parallel with one another.
In the four patients studied, plasma activities rose rapidly, and within 24 to 40 hrs reached peaks of 0-1 to 0-5 per cent. of the radioactivity present in the 30-min. synovial fluid sample. The plasma activities then fell more slowly than the synovial fluid activities in the injected joint. Synovial fluid activities from the non-injected (right) knees showed levels nearly identical to those of the plasma (Fig. 7) . All the plasma and non-injected joint samples tested approached 70 per cent. TCA-precipitability.
AUITORADIOGRAPHY
The autoradiographs performed on sections of rheumatoid synovial membrane removed 4 days after intra-articular injection of labelled RF demonstrated intracellular radioactivity of fixed tissue mononuclear cells (Fig. 8) .
Summary of transport data After intravenous injection of the labelled rheumatoid factor (RF), plasma specific activity fell very rapidly at first and then showed a slower linear rate of fall. The antiglobulin rapidly entered the synovial fluid, equilibrated, and fell in parallel with the plasma levels. When the RF was injected directly into a joint, the specific activity in that synovial fluid fell in a rapid and near linear fashion. The labelled RF rapidly entered the plasma and the contralateral (non-injected) knee joint, where activities quickly reached peaks and then slowly declined in parallel at constant linear rates.
Discussion
Although the purified IgM used in this study contained only kappa type light chains, it appeared to consist of a heterogeneous population of antiglobulins. The biological heterogeneity of the IgM was illustrated by its behaviour in vitro during the isolation procedure, and by its subsequent activity in vivo. When the IgG-IgM cryoglobulin was chromatographed at pH 4 * 6, the IgM remained in part bound to IgG; gel filtration at pH 3 0, however, gave a complete separation of IgG and IgM components. Furthermore, on a mg. per mg. basis, the IgM separated at pH 3 0 had a higher antiglobulin titre (1:10,240) than the IgM obtained at pH 4-6 (1: 1,280). The ability of the strongly acidic buffer to elute the more avid antibody is an indication of biologic heterogeneity among IgM antiglobulin molecules (Allen and Kunkel, 1966) , and similar heterogeneity has previously been demonstrated for RF present in the sera of patients with rheumatoid arthritis (Williams and Kunkel, 1963; Franklin and Fudenberg, 1965) . Thus, the labelled IgM appeared to contain a heterogeneous population of antiglobulins which differed in their avidity for IgG.
After the intravenous injection of the labelled IgM, much of the more avid population of antiglobulin molecules presumably formed large tightlybound complexes with circulating IgG; these immune complexes would be rapidly sequestered and destroyed by the systemic reticulo-endothelial system or elsewhere. These events were thought to be reflected in the initial steep decline of the plasmaspecific activity and by the early appearance of group.bmj.com on June 16, 2017 -Published by http://ard.bmj.com/ Downloaded from abundant free iodine in the urine. Similarly shaped serum decay curves for circulating immune complexes have previously been described (Strober, Wochner, Barlow, McFarlin, and Waldmann, 1968) . The less avid population of the injected antiglobulin presumably formed smaller or less tightly bound complexes with IgG and was catabolized at a slower constant rate, as reflected in the second part of the plasma activity curves. A dynamic equilibrium between RF and denatured IgG has previously been demonstrated in vitro (Aho and Simons, 1963) ; a similar equilibrium may have existed between the plasma IgG and the less avid labelled antiglobulin in vivo. Both the avid and less avid RF readily traversed the synovial membrane. However, the avid RF appeared to be rapidly sequestered and destroyed within the joint space, whereas the less avid RF equilibrated between the plasma and synovial compartments. These events were illustrated by the initial steep fall of the synovial curves and by their subsequent gradual decline, which paralleled the plasma curves.
Another explanation for the rapid initial catabolism of the labelled material would be the presence of significant amounts of denatured IgM in our preparation. This seems unlikely, however, for several reasons. First, the injected IgM retained its biological activity as demonstrated by its antiglobulin titre of 1: 1,280 at a concentration of 0 6 mg./ml. Further evidence for intact biological activity was the cryoprecipitation of 80 per cent. of the labelled IgM when exposed to normal IgG at 4°C. for 12 hrs. Secondly, when the IgM content of our preparation was measured by quantitative complement-fixation, a smooth-shaped curve was obtained and no anticomplementary activity was present. This indicated that the material contained no aggregated IgM.
The rapid near linear fall in synovial fluid activity and the immediate rapid rise in plasma activity after the intra-articular injection of the labelled antiglobulin demonstrate the ease with which RF crosses the synovial membrane. The fact that these synovial samples contained mainly TCA-precipitable counts does not exclude significant sequestration of antiglobulin within the joint. Although only 5 to 10 per cent. of the counts were non-TCA-precipitable, this may represent a considerable amount of sequestered antibody. The initial dose injected intra-articularly was very large, particularly when confined to the relatively restricted synovial space. Indeed, it is likely that much of the more avid RF was immediately trapped and destroyed within the joint. This would explain the failure to observe an initial steep decline in the curves of both the plasma and contralateral synovial fluid after intra-articular injection of the labelled RF. It is possible, however, that the more avid RF did enter the circulation, and that its catabolism was masked by the slow entry of the antiglobulin into the large plasma compartment.
A similar experiment, using a labelled IgM cold agglutinin, was recently performed in patients with rheumatoid arthritis (Brown and others, 1968) . After intravenous administration of the IgM, the plasmaspecific activities fell in an exponential manner; no steep component was observed and equilibration between intra-and extravascular compartments was reached by 20 to 120 hrs. Plasma catabolism of the IgM then proceeded at constant fractional rates. Synovial fluid activities rose gradually and then fell in parallel with the plasma curves, indicating a dynamic equilibrium between plasma and joint IgM. The less avid population of our labelled antiglobulin behaved in a manner similar to the IgM cold agglutinin. This can be illustrated by comparing the total synovial fluid radioactivity (after intravenous administration of labelled IgM) with the percentage of activity which was TCA-precipitable (Fig. 5) . The lower synovial curve (A -------A ) reflects the behaviour of the less avid antibody, and the hatched-in area was considered to represent free iodine released from avid antibody which had been complexed, sequestered, and broken down within the synovial space.
Several observations suggested that some of the extravascular sequestration of labelled RF occurred within the inflamed joints. First, synovial fluid activities reached their peaks while the plasmaspecific activities were falling, suggesting synovial trapping of intravenously-injected antiglobulin. Secondly, the synovial fluid activities showed an initial sharp fall which paralleled the steeply declining part of the plasma curves; this was thought to reflect synovial complexing and removal of the more avid RF molecules. Thirdly, the free iodine present in the initial synovial fluid samples (non-TCAprecipitable activity) persisted for up to 48 hrs and accounted for as much as 80 per cent. of total counts. Since 98 per cent. of the 125I was shown to be attached to the IgM before injection, the presence and persistence of free iodine within the joint strongly suggested synovial destruction of the labelled antiglobulin. Indeed, the rheumatoid joint has been shown to be a rich source of denatured IgG (Hannestad, 1967) , the specific antigen for the labelled antiglobulin. In the present study, the behaviour of the RF was nearly identical in the patients with rheumatoid, psoriatic, or traumatic arthritis, suggesting that denatured IgG may exist in any inflamed joint. It would seem, therefore, that the inflamed synovium, irrespective of the underlying disease, can remove and destroy circulating avid RF. The concept of RF sequestration within joints is well established. Previous studies in rheumatoid patients have demonstrated IgG-IgM complexes within synovial fluid white cells from which free RF can be eluted (Astorga and Bollet, 1965) . In this study, the autoradiographs of the synovial membrane, showing radioactivity within fixed tissue mononuclear cells, further suggest antiglobulin sequestration by the synovial reticuloendothelial system.
The ability of the inflamed synovial space rapidly to complex and sequester the more avid RF would suggest that the RF detectable in synovial fluid by conventional techniques depends primarily on the presence of less avid RF. In contrast, the ability of less avid RF to equilibrate freely across the synovial membrane would permit a concentration gradient to develop in favour of the plasma. Thus, the contribution of serum RF to the synovial pool of detectable RF appears to depend on the amount of less avid serum RF.
The synovial sequestration of RF may be responsible for the depression of synovial fluid complement in patients with rheumatoid arthritis (Hedberg, 1964; Pekin and Zvaifler, 1964) . Assuming that the interaction of more avid RF with IgG leads to complement utilization (Davis, 1966; Fish, Michael, Gewurz and Good, 1966) , the presence of predominantly avid RF might explain in part the depression of synovial fluid complement in rheumatoid patients whose synovial fluid contains no detectable RF. Avid RF which is rapidly bound and sequestered would not be detected by conventional techniques.
Summary
Catabolism and serum-synovial transport of a purified rheumatoid factor (RF) were studied in five patients with inflammatory joint disease. The RF isolated from a mixed (IgG-IgM) cryoglobulin contained a heterogeneous population of antiglobulins which differed in their avidity for IgG. After intravenous administration, the more avid RF presumably complexed to IgG and these immune complexes were rapidly eliminated from the circulation. The less avid RF equilibrated freely between the plasma and synovial compartments and was catabolized slowly. Both the avid and less avid RF traversed the synovial membrane; however, the avid RF was rapidly eliminated within the synovial space. After intra-articular injection, the less avid RF quickly appeared in the plasma and in the noninjected joints, whereas the more avid RF was apparently sequestered within the injected joints. These observations suggest:
(a) that immune elimination of avid RF occurs within the plasma and synovial spaces, 
